{"id":"https://openalex.org/W4361918534","doi":"https://doi.org/10.1158/1078-0432.22458881","title":"Supplementary Figure Legends and Materials and Methods from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer","display_name":"Supplementary Figure Legends and Materials and Methods from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361918534","doi":"https://doi.org/10.1158/1078-0432.22458881"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22458881","doi":"https://doi.org/10.1158/1078-0432.22458881","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22458881","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22458881","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101121354","display_name":"Yoshiaki Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiaki Yamamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046154045","display_name":"Paulo J.C. Lin","orcid":"https://orcid.org/0000-0002-9310-1366","observed_orcids":["https://orcid.org/0000-0002-9310-1366"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paulo J.C. Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038938817","display_name":"Eliana Beraldi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eliana Beraldi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100403554","display_name":"Fan Zhang","orcid":"https://orcid.org/0000-0001-5130-9380","observed_orcids":["https://orcid.org/0000-0001-5130-9380","https://orcid.org/0000-0003-2029-298X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fan Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101198988","display_name":"Yoshihisa Kawai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshihisa Kawai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034007787","display_name":"Jeffrey W. Leong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Leong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069866009","display_name":"Hidemasa Katsumi","orcid":"https://orcid.org/0000-0001-5078-7276","observed_orcids":["https://orcid.org/0000-0001-5078-7276"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hidemasa Katsumi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034110828","display_name":"Ladan Fazli","orcid":"https://orcid.org/0009-0005-0731-0583","observed_orcids":["https://orcid.org/0009-0005-0731-0583","https://orcid.org/0000-0001-6488-4245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ladan Fazli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002714515","display_name":"Robert Fraser","orcid":"https://orcid.org/0000-0003-3771-4544","observed_orcids":["https://orcid.org/0000-0003-3771-4544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Fraser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050350074","display_name":"Pieter R. Cullis","orcid":"https://orcid.org/0000-0001-9586-2508","observed_orcids":["https://orcid.org/0000-0001-9586-2508"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pieter R. Cullis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062125605","display_name":"Martin Edwin Gleave","orcid":"https://orcid.org/0000-0003-4235-0167","observed_orcids":["https://orcid.org/0000-0003-4235-0167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Gleave","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6929000020027161,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6929000020027161,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14364","display_name":"Clusterin in disease pathology","score":0.2793000042438507,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clusterin","display_name":"clusterin","score":0.7799999713897705},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.7089999914169312},{"id":"https://openalex.org/keywords/enzalutamide-resistance","display_name":"enzalutamide resistance","score":0.9570000171661377},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.7950000166893005},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/metastasis-progression","display_name":"metastasis progression","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.7732145190238953},{"id":"https://openalex.org/C2779476363","wikidata":"https://www.wikidata.org/wiki/Q14864935","display_name":"Clusterin","level":3,"score":0.7612965106964111},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7354329228401184},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.652524471282959},{"id":"https://openalex.org/C85265743","wikidata":"https://www.wikidata.org/wiki/Q885458","display_name":"Blot","level":3,"score":0.5547488927841187},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38529810309410095},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34894710779190063},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.332097589969635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3312891721725464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24434208869934082},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.15125787258148193},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13000783324241638},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22458881","doi":"https://doi.org/10.1158/1078-0432.22458881","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22458881","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22458881.v1","doi":"https://doi.org/10.1158/1078-0432.22458881.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22458881.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22458881","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_and_Materials_and_Methods_from_siRNA_Lipid_Nanoparticle_Potently_Silences_Clusterin_and_Delays_Progression_When_Combined_with_Androgen_Receptor_Cotargeting_in_Enzalutamide-Resistant_Prostate_Cancer/22458881","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22458881","doi":"https://doi.org/10.1158/1078-0432.22458881","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22458881","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361951818","https://openalex.org/W2066250957","https://openalex.org/W2306329738","https://openalex.org/W2022370900","https://openalex.org/W2059892851","https://openalex.org/W2556873809","https://openalex.org/W7099438485","https://openalex.org/W4416657474","https://openalex.org/W2980206361","https://openalex.org/W2084891840"],"abstract_inverted_index":{"Supplementary":[0,4],"Figure":[1],"Legends":[2],"S1-4.":[3],"Materials":[5],"and":[6],"Methods:":[7],"Antibodies":[8],"used":[9],"for":[10],"western":[11],"blotting.":[12]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}